ORACLE INVESTMENT MANAGEMENT INC - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 86 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2014. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
ORACLE INVESTMENT MANAGEMENT INC ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$13,680,598
-49.0%
1,638,395
-18.7%
4.20%
-78.7%
Q2 2023$26,806,084
+14.9%
2,015,4950.0%19.75%
-12.6%
Q1 2023$23,339,432
+32.3%
2,015,495
-9.4%
22.59%
+53.5%
Q4 2022$17,647,321
+118.2%
2,224,807
+59.7%
14.72%
+220.4%
Q3 2022$8,087,000
+127.6%
1,393,165
+73.3%
4.59%
+325.8%
Q2 2022$3,553,000
-68.1%
803,845
-34.4%
1.08%
-51.1%
Q1 2022$11,151,000
-61.9%
1,225,395
-17.6%
2.20%
-46.9%
Q4 2021$29,246,000
-20.9%
1,487,652
-0.1%
4.16%
-9.7%
Q3 2021$36,969,000
-23.1%
1,488,659
+8.3%
4.60%
-30.5%
Q2 2021$48,054,000
-1.3%
1,374,159
-11.1%
6.62%
-9.2%
Q1 2021$48,687,000
+9.0%
1,546,459
-10.2%
7.29%
+30.3%
Q4 2020$44,655,000
+162.8%
1,721,4590.0%5.60%
+149.9%
Q3 2020$16,991,000
+273.0%
1,721,459
+30.4%
2.24%
+287.4%
Q2 2020$4,555,000
+22.0%
1,320,359
+8.2%
0.58%
-47.9%
Q1 2020$3,734,000
-34.6%
1,220,359
+9.9%
1.11%
+3.5%
Q4 2019$5,709,000
-0.4%
1,110,6660.0%1.07%
-24.0%
Q3 2019$5,731,000
-14.7%
1,110,6660.0%1.41%
-2.5%
Q2 2019$6,720,000
-16.4%
1,110,666
-31.0%
1.45%
-15.5%
Q1 2019$8,043,000
-58.1%
1,610,666
-63.9%
1.71%
-71.3%
Q4 2018$19,208,000
-62.2%
4,467,364
-52.7%
5.96%
-46.5%
Q3 2018$50,833,000
+47.5%
9,437,634
-2.8%
11.13%
+33.6%
Q2 2018$34,452,000
+76.2%
9,704,761
+1.8%
8.33%
+75.8%
Q1 2018$19,552,000
-12.4%
9,537,661
+12.8%
4.74%
+6.8%
Q4 2017$22,317,000
-51.1%
8,453,375
-2.7%
4.43%
-40.7%
Q3 2017$45,604,000
+55.1%
8,686,455
+5.2%
7.48%
+61.0%
Q2 2017$29,403,000
+3.3%
8,259,380
+50.0%
4.64%
+4.6%
Q1 2017$28,470,000
+35.8%
5,506,732
-0.2%
4.44%
+27.7%
Q4 2016$20,964,000
-53.2%
5,516,894
+10.4%
3.48%
-49.6%
Q3 2016$44,787,000
+100.1%
4,998,566
+57.1%
6.90%
+32.5%
Q2 2016$22,387,000
-15.9%
3,182,269
-3.9%
5.21%
-24.7%
Q1 2016$26,610,000
-44.6%
3,312,089
-9.4%
6.92%
-16.8%
Q4 2015$48,009,000
+102.7%
3,656,431
-43.5%
8.32%
+243.3%
Q3 2015$23,688,000
+26.9%
6,472,322
+99.7%
2.42%
+6.9%
Q2 2015$18,673,000
-2.7%
3,241,761
-1.3%
2.27%
-6.9%
Q1 2015$19,183,000
-24.3%
3,284,796
+1.7%
2.43%
-26.7%
Q4 2014$25,327,000
+59.9%
3,230,518
+0.2%
3.32%
+51.6%
Q3 2014$15,837,000
-99.9%
3,225,518
+7.4%
2.19%
-2.7%
Q2 2014$18,555,499,000
+34.7%
3,002,508
+16.6%
2.25%
+43.1%
Q1 2014$13,780,150,000
+2.3%
2,575,7290.0%1.57%
-15.1%
Q4 2013$13,471,062,000
+24.4%
2,575,729
+31.3%
1.85%
+20.1%
Q3 2013$10,828,518,000
+118.2%
1,961,6880.0%1.54%
+80.4%
Q2 2013$4,963,071,0001,961,6880.86%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q1 2014
NameSharesValueWeighting ↓
WATER ISLAND CAPITAL LLC 4,718,964$24,255,0001.69%
HighVista Strategies LLC 378,479$1,945,0001.48%
Exane Asset Management 198,743$1,021,539,0001.26%
ORACLE INVESTMENT MANAGEMENT INC 1,110,666$5,709,0001.07%
BOURNE LENT ASSET MANAGEMENT INC 441,650$2,270,0001.07%
Versor Investments LP 3,148,691$16,184,0000.82%
Magnetar Financial LLC 6,919,655$35,567,0000.74%
AQR Arbitrage LLC 6,953,621$35,742,0000.60%
GABELLI & Co INVESTMENT ADVISERS, INC. 915,124$4,704,0000.54%
Bellevue Group AG 5,734,309$29,474,0000.47%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders